Thursday, January 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

U.S. Army Seeks Leishmaniasis Rapid Diagnostic Device

by Stephanie Lizotte
January 1, 2012
Leishmaniasis

a patient who’d been ill with leishmaniasis, having been infected with Leishmania sp. protozoa, which had manifested itself as a cutaneous form of the disease. Credit: CDC - Dr. Martins Castro, San Paulo, Brazil; Dr. Lucille K. Georg

The U.S. Army Medical Material Development Activity (USAMMDA) is conducting market research to survey available or emerging technologies for a diagnostic device to rapidly diagnose cutaneous leishmaniasis. Ideally the device would be used in point-of-care settings.

Manufacturing of the device would need to comply with cGMP requirements as FDA clearance would be ultimately required.

Candidate devices should be at the Technology Readiness Level 5 (TRL 5). If the device development is at the proof of concept stage (TRL 3) and current manufacturing is not cGMP, companies should include a gap analysis and estimated time by which cGMP manufacturing could be achieved.

Additional requirements on sensitivity, specificity and shelf-life are outlined in the formal announcement here. The response deadline is 12 January, 2012.

Tags: LeishmaniasisPOC DiagnosticsRFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC